Posaconazole Plasma Concentrations in Critically Ill Patients

Posaconazole-Induced Topiramate Toxicity

(2013) Deborah Marriott et al.   ANNALS OF INTERNAL MEDICINE

Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma

(2010) S H Jang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers

(2009) E. S. Dodds Ashley et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

(2009) L. A. Wenning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience

(2009) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

(2009) Roger J. M. Brüggemann et al.   CLINICAL INFECTIOUS DISEASES

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management

(2009) S.C.A. Chen et al.   CLINICAL MICROBIOLOGY AND INFECTION

Effects of oral posaconazole on the pharmacokinetics of sirolimus

(2009) Allen Moton et al.   CURRENT MEDICAL RESEARCH AND OPINION

Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects

(2008) J. E. Conte et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Posaconazole

(2008) James E Frampton et al.   DRUGS